References
Jayaraman T et al (2008) TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag 4(4):805–817
Chalouhi N, Hoh BL, Hasan D (2013) Review of cerebral aneurysm formation, growth, and rupture. Stroke 44(12):3613–3622
Toubiana J et al (2016) Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood 127(25):3154–3164
Huang J et al (2005) Intracranial aneurysms in the pediatric population: case series and literature review. Surg Neurol 63(5):424–432
Backes D et al (2016) Patient- and aneurysm-specific risk factors for intracranial aneurysm growth. Stroke 47(4):951–957
Nagel MA, Gilden D (2016) Developments in varicella zoster virus vasculopathy. Curr Neurol Neurosci Rep 16(2):12
Atchaneeyasakul K et al (2018) Association of hypothyroidism with unruptured cerebral aneurysms: a case-control study. J Neurosurg 128(2):511–514
Nagashima T et al (2000) Cerebral vasculitis in chronic mucocutaneous candidiasis: autopsy case report. Neuropathology 20(4):309–314
Scott O et al (2021) STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses. NPJ Genom Med 6(1):34
Zhou HF et al (2013) CD43-mediated IFN-γ production by CD8+ T cells promotes abdominal aortic aneurysm in mice. J Immunol 190(10):5078–5085
Marinković G et al (2013) Immunosuppressive drug azathioprine reduces aneurysm progression through inhibition of Rac1 and c-Jun-terminal-N-Kinase in endothelial cells. Arterioscler Thromb Vasc Biol 33(10):2380–2388
Shimizu K et al (2004) Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Investig 114(2):300–308
Bernal S et al (2021) Protective effect of suppressor of cytokine signalling 1-based therapy in experimental abdominal aortic aneurysm. Br J Pharmacol 178(3):564–581
Forbes LR et al (2018) Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol 142(5):1665–1669
Chandesris M-O et al (2012) Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency. Circ Cardiovasc Genet 5(1):25–34
Regis G et al (2008) Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol 19(4):351–359
Albasanz-Puig A et al (2012) Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochem Biophys Res Commun 428(1):179–184
Lee S et al (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130(4):691–703
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This study was approved by the NIH Institutional Review Board (IRB) and Office of Ethics at NIAID. We certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Bierman-Chow, S., Freeman, A.F., Holland, S.M. et al. Cerebral aneurysm in three pediatric patients with STAT1 gain-of-function mutations. J Neurol 269, 5638–5642 (2022). https://doi.org/10.1007/s00415-022-11131-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-11131-w